search
pharmaceutical companies
Trends
- 1Kobayashi Pharmaceutical weighs takeover offer above ¥500 billion●Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deat
Kobayashi Pharmaceutical, the Japanese company at the center of a supplement contamination scandal linked to suspected deaths, is reportedly considering a buyout offer worth more than ¥500 billion. The news has drawn attention given the company's damaged reputation and the uncertain future of its consumer health business following the red yeast rice supplement scandal.
- 2European capital to help Colombian biotech firm produce 250 million vaccines●Europe Injects Capital into Colombian Biotech Firm to Produce 250 Million Vaccines
A Colombian biotechnology company has received European investment to expand vaccine production, with plans to manufacture up to 250 million doses. The deal reflects Europe's push to strengthen global vaccine supply chains and Latin America's growing role in pharmaceutical manufacturing. Details on the investors and timelines have not yet been widely reported.
- 3
Anthropic has established its own wet laboratory as it expands its AI-driven drug discovery programme, according to Reuters. The lab will let the company test biological hypotheses generated by its AI models in real experiments. Observers see it as a notable step for an AI firm moving from software into hands-on biology and pharmaceutical research.